Join or Sign In

Sign in to add and modify your software

Sign in with Facebook Sign in with email

By joining Download.com, you agree to our Terms of Use and acknowledge the data practices in our Privacy Agreement.

Adapted01 Breast Cancer for Android

Developer's Description

Oncotype DX (ODX) is a commercially available genetic profiling test that predicts recurrence risk and benefits of addition of chemotherapy for ER+, HER2-, lymph-node negative breast cancer patients; ODX evaluates expression of 21 genes and calculates a recurrence score (RS) from 0-100, with higher scores indicating greater likelihood of recurrence based on TAILORx clinical trial results. TAILORx trial shows that in patients with a high RS (26-100), the administration of adjuvant chemotherapy significantly reduces cancer recurrence and mortality, while patients with a low RS (0-25) receive no additional benefit from chemotherapeutic treatment. While performance of ODX gives personalized prognostic and predictive information for individual breast cancer patients, this test is expensive with high costs for patient and healthcare system. A decision support system, called ADAPTED01, was designed in a retrospective study to predict RS 25 and adequately select requests of ODX based on quantitative immunochemistry analysis [estrogen receptor (ER), progesterone receptor (PR), proliferation indices (Ki-67)].

Oncotype DX (ODX) is a commercially available genetic profiling test that predicts recurrence risk and benefits of addition of chemotherapy for ER+, HER2-, lymph-node negative breast cancer patients; ODX evaluates expression of 21 genes and calculates a recurrence score (RS) from 0-100, with higher scores indicating greater likelihood of recurrence based on TAILORx clinical trial results. TAILORx trial shows that in patients with a high RS (26-100), the administration of adjuvant chemotherapy significantly reduces cancer recurrence and mortality, while patients with a low RS (0-25) receive no additional benefit from chemotherapeutic treatment. While performance of ODX gives personalized prognostic and predictive information for individual breast cancer patients, this test is expensive with high costs for patient and healthcare system. A decision support system, called ADAPTED01, was designed in a retrospective study to predict RS 25 and adequately select requests of ODX based on quantitative immunochemistry analysis [estrogen receptor (ER), progesterone receptor (PR), proliferation indices (Ki-67)].

Full Specifications

What's new in version 1.0

General

Release October 9, 2020
Date Added October 9, 2020
Version 1.0

Operating Systems

Operating Systems Android
Additional Requirements Requires Android 5.0 and up

Popularity

Total Downloads 0
Downloads Last Week 0
Report Software

Related Apps

Fitbit

Free
Fitbit

Calorie Counter - MyFitnessPal

Free
Calorie Counter - MyFitnessPal

Medscape

Free
Medscape

Epocrates

Free
Epocrates

Best VPN Services for 2021

Best for privacy

3 months free with 1-year plan

Best for customer support

$39.99 for the first 12 months

Best for zero logs

$4.87.99/months for a 1-year plan

Best money-back guarantee

$2.99/months for a 3-year plan